Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Development of innovative antimicrobials against pathogens resistant to antimicrobials

    Funds research to develop new antibacterial and antifungal therapies targeting specific drug-resistant pathogens to combat antimicrobial resistance and strengthen EU health leadership.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

    This grant supports research to develop monoclonal antibodies against key emerging viruses, advancing candidates through preclinical and early clinical stages to boost EU pandemic preparedness.

    European CommissionDue Apr 13, 2027$10,000,000

    Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings

    Funds collaborative early-stage research and tool development for new small molecule antibiotics targeting Klebsiella spp. and other Gram-negative Enterobacteriaceae.

    Gates FoundationRolling submissions$5,000,000

    Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

    This grant funds research to discover and develop new small molecule antivirals for specific epidemic-prone viruses, supporting projects from early discovery through early-stage clinical studies.

    European CommissionDue Apr 13, 2027$11,000,000

    Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

    Funds research to develop monoclonal antibody therapies for specific Flaviviruses, advancing clinical candidates and EU outbreak preparedness.

    European CommissionDue Apr 13, 2027$10,000,000

    Research Grants - European Society of Clinical Microbiology and Infectious Diseases

    Research Grants - European Society of Clinical Microbiology and Infectious Diseases support early-career researchers and international teams to advance clinical microbiology and infectious disease research.

    ESCMIDForecasted Sep 15, 2027$180,000Forecasted